about
Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringensAnti-anaerobic activity of antibacterial agents.Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centersbeta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children.Trends in antimicrobial resistance among clinical isolates of the Bacteroides fragilis group from 1992 to 1997 in Montreal, Canada.Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodologySusceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 UDisk diffusion susceptibility testing of the Bacteroides fragilis groupAnti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole.Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD surveillance study.Survey of Bacteroides fragilis group susceptibility patterns in Canada.Susceptibilities of 540 anaerobic gram-negative bacilli to amoxicillin, amoxicillin-BRL 42715, amoxicillin-clavulanate, temafloxacin, and clindamycin.In vitro susceptibilities of the Bacteroides fragilis group to 14 antimicrobial agents in Korea.Susceptibilities of members of the Bacteroides fragilis group to 11 antimicrobial agentsAnnual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.Cefoxitin in the treatment of aerobic and anaerobic infections. Prospective correlation of in vitro susceptibility methods with clinical outcome.beta-Lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents.
P2860
Q24645140-27F70555-4AE5-4EEC-A769-7E5BAC798F0DQ31936097-FBAB75B3-FE5F-42DA-A81D-05B83A3EDBB2Q33744238-5980FFB9-31E8-48CC-B421-16EDCD140F17Q33760528-A164C428-3177-4E44-BC08-85B82443F51BQ33976824-B041A0B2-EA94-4F6B-8947-8C76DAEF5E81Q33977902-990DF790-2739-4D92-BB64-C8F935BECD3CQ35247398-C9F0CA74-F393-4A7B-9908-05CD8E063CDCQ35252834-6BCC99E3-4AB8-4595-9EAD-4D6B4B4773C0Q35269353-2AA11FFD-D543-494E-9C13-3C13E98E1DB5Q35542673-BD65AE6B-D115-4060-918C-D9AF006FB2B3Q35690192-D36BA73E-E299-4132-97E0-07D6B95DCFFBQ35806399-1328645B-09A6-42C8-99D6-5A1950456555Q35825806-2932A519-8CC7-4DB1-B1CD-245439A08C3FQ35836795-5F86D799-988F-4BCE-86A9-92C657176D08Q35843670-62332A9F-9AB8-4E6B-BCF6-01E988DF3C07Q35900710-F83CCDA4-9DDC-43C2-95FE-90D52A45CFF7Q37158142-D5845103-3252-44B1-90F1-6B8F0F3D2CA7Q44666933-B197FEBD-01FD-4A58-A40A-17A686D91FE7Q54259559-8E952F32-D7F8-4A73-8DA9-2B7F0848A7C7
P2860
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Survey of anaerobic susceptibility patterns in Canada.
@ast
Survey of anaerobic susceptibility patterns in Canada.
@en
type
label
Survey of anaerobic susceptibility patterns in Canada.
@ast
Survey of anaerobic susceptibility patterns in Canada.
@en
prefLabel
Survey of anaerobic susceptibility patterns in Canada.
@ast
Survey of anaerobic susceptibility patterns in Canada.
@en
P2093
P2860
P356
P1476
Survey of anaerobic susceptibility patterns in Canada.
@en
P2093
P2860
P304
P356
10.1128/AAC.30.5.798
P407
P577
1986-11-01T00:00:00Z